In summary, NSD1 increased the transcription of WNT10B in HCC, and upstream lncRNAs modulated this interaction by inhibiting (KB-68A7.1) or activating (CTB-193M12.5) NSD1 and WNT10B, thereby contributing to HCC progression. The gene discussed is WNT10B; the disease is hepatocellular carcinoma.